Stay updated on Pembrolizumab for Cancer of Unknown Primary Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Cancer of Unknown Primary Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Cancer of Unknown Primary Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-05-01T03:33:03.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The webpage has been updated to include the study's collaborators, Merck Sharp & Dohme LLC, and the study chair, Harpreet Wasan, MBBS, FRCP, from Imperial College London. Additionally, the revision number has been updated from v2.14.3 to v2.15.0.
    Difference
    53%
    Check dated 2025-04-16T14:25:13.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T23:55:56.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T22:50:49.000Z thumbnail image
  8. Check
    101 days ago
    Change Detected
    Summary
    The web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T15:54:33.000Z thumbnail image
  9. Check
    108 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.1%
    Check dated 2025-02-03T11:00:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Cancer of Unknown Primary Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Cancer of Unknown Primary Clinical Trial page.